Evidence map›Paper›PMID 25120285›Full record

ArticleMediators of inflammation2014

Induction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions.

Lúcia Cristina Jamli Abel, Ludmila Rodrigues Pinto Ferreira, Isabela Cunha Navarro, Monique Andrade Baron, Jorge Kalil, Ricardo Tostes Gazzinelli, Luiz Vicente Rizzo, Edecio Cunha-Neto

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Towards a map of the immune system manipulation network byFrontiers in cellular and infection microbiology · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Lúcia Cristina Jamli AbelLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, 05403-001 São Paulo, SP, Brazil.
Ludmila Rodrigues Pinto FerreiraLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, 05403-001 São Paulo, SP, Brazil ; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, 01246-000 São Paulo, SP, Brazil ; Institute for Investigation in Immunology (III), INCT, 05403-001 São Paulo, SP, Brazil.
Isabela Cunha NavarroLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, 05403-001 São Paulo, SP, Brazil ; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, 01246-000 São Paulo, SP, Brazil ; Institute for Investigation in Immunology (III), INCT, 05403-001 São Paulo, SP, Brazil.
Monique Andrade BaronLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, 05403-001 São Paulo, SP, Brazil ; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, 01246-000 São Paulo, SP, Brazil ; Institute for Investigation in Immunology (III), INCT, 05403-001 São Paulo, SP, Brazil.
Jorge KalilLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, 05403-001 São Paulo, SP, Brazil ; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, 01246-000 São Paulo, SP, Brazil ; Institute for Investigation in Immunology (III), INCT, 05403-001 São Paulo, SP, Brazil.
Ricardo Tostes GazzinelliResearch Center René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), 30190-002 Belo Horizonte, MG, Brazil ; Laboratory of Immunopathology, Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, 31270-910 Belo Horizonte, MG, Brazil ; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Luiz Vicente RizzoHospital Israelita Albert Einstein, Avenida Albert Einstein 627-701, 2 Subsolo Bloco A., 05651-901 São Paulo, SP, Brazil.
Edecio Cunha-NetoLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, 05403-001 São Paulo, SP, Brazil ; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, 01246-000 São Paulo, SP, Brazil ; Institute for Investigation in Immunology (III), INCT, 05403-001 São Paulo, SP, Brazil.
Universidade de São Paulo · BRFundação Oswaldo Cruz · BRHospital Israelita Albert Einstein · BR

Funding

Sao Paulo- MInas Gerais Neglected Tropical Disease Research Center for BiomarkerP50AI098461 · NIAID · FUNDACAO FACULDADE DE MEDICINA · PI FERREIRA, JOAO N · 2012 to 2016
$1.5M
NIAID NIH HHS 1P50AI098461-01NIAID NIH HHS P50 AI098461
6 · The paper itself

Abstract

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is characterized by immunopathology driven by IFN-γ secreting Th1-like T cells. T. cruzi has a thick coat of mucin-like glycoproteins covering its surface, which plays an important role in parasite invasion and host immunomodulation. It has been extensively described that T. cruzi or its products-like GPI anchors isolated from GPI-anchored mucins from the trypomastigote life cycle stage (tGPI-mucins)-are potent inducers of proinflammatory responses (i.e., cytokines and NO production) by IFN-γ primed murine macrophages. However, little is known about whether T. cruzi or GPI-mucins exert a similar action in human cells. We therefore decided to further investigate the in vitro cytokine production profile from human mononuclear cells from uninfected donors exposed to T. cruzi as well as tGPI-mucins. We observed that both living T. cruzi trypomastigotes and tGPI-mucins are potent inducers of IL-12 by human peripheral blood monocytes and this effect depends on CD40-CD40L interaction and IFN-γ. Our findings suggest that the polarized T1-type cytokine profile seen in T. cruzi infected patients might be a long-term effect of IL-12 production induced by lifelong exposure to T. cruzi tGPI-mucins.

Indexed as

CD40 AntigensCD40 LigandCells, CulturedGlycoproteinsGlycosylphosphatidylinositolsHumansInterferon-gammaInterleukin-12MonocytesMucinsProtein BindingTrypanosoma cruziCD40 AntigensCD40 LigandGlycoproteinsGlycosylphosphatidylinositolsInterferon-gammaInterleukin-12Mucins

Identifiers

PMID25120285
PMCPMC4120781
OpenAlexW2150496436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.